| 5557 |
Perception- Concept |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5558 |
Patient needs |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5559 |
Patient perception and Patient Satisfaction |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5696 |
Monitoring of STEPS centres |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5697 |
Interaction of STEPS centre with TB care ecosystem |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5698 |
STEPS centre organogram |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5699 |
Functions of STEPS centre |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5700 |
Role of STEPS centre coordinators |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5702 |
Components of System for TB Elimination in Private Sector (STEPS) |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5703 |
Role of STEPS centre coordinator in TB Prevention & control |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5704 |
Role of STEPS centre Coordinator in Public Health Actions |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5705 |
Role of STEPS centre Coordinator in TB Treatment and Care |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 5706 |
Role of STEPS centre coordinator in Case Finding and Diagnosis |
06/06/2024 |
Partnerships and Multisectoral Engagement |
| 847 |
Stocking Norms of Drugs and Supplies |
06/06/2024 |
Procurement and supply chain management |
| 848 |
Buffer Stocks |
06/06/2024 |
Procurement and supply chain management |
| 849 |
Storage norms |
06/06/2024 |
Procurement and supply chain management |
| 851 |
Supply Chain Processes under NTEP |
06/06/2024 |
Procurement and supply chain management |
| 852 |
Indenting |
06/06/2024 |
Procurement and supply chain management |
| 853 |
Receipt of Drugs/consumables |
06/06/2024 |
Procurement and supply chain management |
| 854 |
Storage of Drugs |
06/06/2024 |
Procurement and supply chain management |
| 856 |
Drug Consumption |
06/06/2024 |
Procurement and supply chain management |
| 868 |
Schedule H-1 Regulation |
06/06/2024 |
Procurement and supply chain management |
| 975 |
Second Line anti TB drugs |
06/06/2024 |
Procurement and supply chain management |
| 1015 |
Role of the State Drug Store [SDS] in the Constitution of Patient-wise Boxes |
06/06/2024 |
Procurement and supply chain management |
| 1020 |
Rationale for Grouping of Anti-TB Drugs |
06/06/2024 |
Procurement and supply chain management |
| 1021 |
Drugs Not Included in Groups A - C and Rationale for Non-inclusion |
06/06/2024 |
Procurement and supply chain management |
| 1092 |
Quality Assurance of Anti-TB Drugs |
06/06/2024 |
Procurement and supply chain management |
| 2221 |
Classification of Stock types |
06/06/2024 |
Procurement and supply chain management |
| 25 |
Anti-TB Drugs and formulations |
06/06/2024 |
Procurement and supply chain management |
| 40 |
Supply Chain Management |
06/06/2024 |
Procurement and supply chain management |
